| Non-invasive markers for hepatic fibrosis A Baranova, P Lal, A Birerdinc, ZM Younossi BMC gastroenterology 11, 1-15, 2011 | 426 | 2011 |
| Non‐alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population‐based study L Gerber, M Otgonsuren, A Mishra, C Escheik, A Birerdinc, M Stepanova, ... Alimentary pharmacology & therapeutics 36 (8), 772-781, 2012 | 244 | 2012 |
| Adipose tissue as an endocrine organ C McGown, A Birerdinc, ZM Younossi Clinics in liver disease 18 (1), 41-58, 2014 | 218 | 2014 |
| Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non‐alcoholic fatty liver disease A Baranova, TP Tran, A Birerdinc, ZM Younossi Alimentary pharmacology & therapeutics 33 (7), 801-814, 2011 | 218 | 2011 |
| Caffeine is protective in patients with non‐alcoholic fatty liver disease A Birerdinc, M Stepanova, L Pawloski, ZM Younossi Alimentary pharmacology & therapeutics 35 (1), 76-82, 2012 | 192 | 2012 |
| A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis ZM Younossi, S Page, N Rafiq, A Birerdinc, M Stepanova, N Hossain, ... Obesity surgery 21, 431-439, 2011 | 190 | 2011 |
| Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples R Mehta, A Birerdinc, N Hossain, A Afendy, V Chandhoke, Z Younossi, ... BMC Molecular Biology 11, 1-10, 2010 | 136 | 2010 |
| Protein partners of KCTD proteins provide insights about their functional roles in cell differentiation and vertebrate development M Skoblov, A Marakhonov, E Marakasova, A Guskova, V Chandhoke, ... Bioessays 35 (7), 586-596, 2013 | 100 | 2013 |
| Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS) A Baranova, TP Tran, A Afendy, L Wang, A Shamsaddini, R Mehta, ... Journal of translational medicine 11, 1-8, 2013 | 93 | 2013 |
| Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity M Stepanova, E Rodriguez, A Birerdinc, A Baranova Oncotarget 6 (3), 1414, 2015 | 91 | 2015 |
| Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences ZM Younossi, A Birerdinc, L Henry Journal of hepatology 65 (1), S109-S119, 2016 | 89 | 2016 |
| Manipulating molecular switches in brown adipocytes and their precursors: a therapeutic potential A Birerdinc, M Jarrar, T Stotish, M Randhawa, A Baranova Progress in lipid research 52 (1), 51-61, 2013 | 56 | 2013 |
| Non-invasive diagnostic tests for non-alcoholic fatty liver disease JM Estep, A Birerdinc, Z Younossi Current molecular medicine 10 (2), 166-172, 2010 | 47 | 2010 |
| Expression of genes for micro RNA‐processing enzymes is altered in advanced non‐alcoholic fatty liver disease H Sharma, M Estep, A Birerdinc, A Afendy, A Moazzez, H Elariny, ... Journal of Gastroenterology and Hepatology 28 (8), 1410-1415, 2013 | 36 | 2013 |
| Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region A Birerdinc, E Nohelty, A Marakhonov, G Manyam, I Panov, S Coon, ... Tumor Biology 31, 33-45, 2010 | 36 | 2010 |
| The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin ZM Younossi, A Birerdinc, M Estep, M Stepanova, A Afendy, A Baranova Journal of translational medicine 10, 1-10, 2012 | 35 | 2012 |
| Emerging therapies for hepatitis C virus A Birerdinc, ZM Younossi Expert opinion on emerging drugs 15 (4), 535-544, 2010 | 31 | 2010 |
| Multiple factors predict physical performance in people with chronic liver disease A Loria, K Doyle, AA Weinstein, P Winter, C Escheik, J Price, L Wang, ... American Journal of Physical Medicine & Rehabilitation 93 (6), 470-476, 2014 | 30 | 2014 |
| KPP: KEGG pathway painter G Manyam, A Birerdinc, A Baranova BMC Systems Biology 9, 1-4, 2015 | 26 | 2015 |
| Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example S Page, A Birerdinc, M Estep, M Stepanova, A Afendy, E Petricoin, ... PloS one 8 (2), e56009, 2013 | 22 | 2013 |
